ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,068.00
      -0.06%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.67%
      Bitcoin
      66,748.50
      2.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Biogen Inc (0R1B)

      7. Biogen Inc (0R1B) News

      0R1B

      Biogen (0R1B)

      Biogen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:0R1B
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      03/06/20247:30AMUK RegulatoryNew Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene TherapyLSE:0R1BBiogen Inc
      03/04/20244:15PMUK RegulatoryBiogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual MeetingLSE:0R1BBiogen Inc
      02/23/20247:00AMUK RegulatoryBiogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMPLSE:0R1BBiogen Inc
      02/12/20244:06PMUK RegulatoryBiogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s AtaxiaLSE:0R1BBiogen Inc
      01/31/20247:30AMUK RegulatoryBiogen to Realign Resources for Alzheimer's Disease FranchiseLSE:0R1BBiogen Inc
      08/06/202312:07PMAlliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:0R1BBiogen Inc
      08/06/20239:17AMAlliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:0R1BBiogen Inc
      06/09/20237:12AMAlliance NewsAlliance News*Nasdaq halts trading of Biogen stockLSE:0R1BBiogen Inc
       Showing the most relevant articles for your search:LSE:0R1B